Who Paid My Doc
General - Pelvic Organ Prolapse
Device Pelvic Organ Prolapse
General payments
$301,212
Research payments
$339,972
Through program year 2022, $301,212 in general payments and $339,972 in research payments were reported against General - Pelvic Organ Prolapse (Pelvic Organ Prolapse).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | General | $70,568 | 6 |
| 2022 | Research | $111,487 | 4 |
| 2021 | General | $172 | 3 |
| 2020 | General | $128,066 | 154 |
| 2020 | Research | $228,485 | 4 |
| 2019 | General | $102,405 | 14 |
Breakdown
Each share is of general payments naming this product in 2021.
Each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2021 where a state was reported.
Records
177 general · 8 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.